Posted in | News | Lithium | Mining Business

Atlas Lithium's Neves Project is Now Permitted

Atlas Lithium Corporation ("Atlas Lithium"), a leading lithium exploration and development company, is pleased to announce that it received the operational permit for its Neves Project from the government of the state of Minas Gerais in Brazil. With this positive decision, Atlas Lithium has all the needed authorizations to assemble and run its processing plant and develop open-pit mining operations at one of its lithium deposits. This marks a crucial milestone in the Company's goal of becoming a lithium producer.

On October 25, 2024, a voting board comprised of twelve representatives from the local civil society and government unanimously approved Atlas Lithium's license application for its Neves Project, resulting in the formal issuance of the permit. On October 26, 2024, the permit was formally published in the official gazette of the Minas Gerais government. This outcome follows the technical recommendation for approval issued by the Environmental Foundation of Minas Gerais in September 2024.

The permit authorizes Atlas Lithium to assemble and operate its lithium processing plant, to process mined ore from one of its deposits at the facility, and to sell the lithium concentrate that it produces. This key development comes after an extensive technical review process by regulatory agencies that began with the Company's initial permit application on September 1, 2023. The triphasic permit obtained by Atlas Lithium is the most expeditious licensing modality available as it encompasses the initial, the installation, and the operating licenses all within this same issued authorization (known as "LI/LP/LO" in the local regulatory terminology).

Marc Fogassa, CEO of Atlas Lithium, commented, "We are thrilled with today's announcement, as permitting is widely considered the most critical risk in any mining project. Atlas Lithium's permit reflects fourteen months of our team's meticulous work throughout the licensing process and showcases our unwavering commitment to developing an environmentally responsible and sustainable operation in Brazil's Lithium Valley - a mineral district which is rapidly establishing itself as a premier location in the global lithium supply chain. This milestone marks a key step for us towards becoming a lithium producer and advances Atlas Lithium into the next phase of our growth trajectory."

"We are committed to being a responsible corporate citizen for all our stakeholders. With the news provided today, and as the Neves Project proceeds towards implantation and operation, Atlas Lithium will create hundreds of local jobs in the Vale do Jequitinhonha area of Minas Gerais. Additionally, our lithium processing plant is engineered to possibly achieve the smallest environmental footprint in its class," said Rodrigo Menck, a member of the Board of Directors of the Company.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Atlas Lithium Corporation. (2024, October 30). Atlas Lithium's Neves Project is Now Permitted. AZoMining. Retrieved on November 21, 2024 from https://www.azomining.com/News.aspx?newsID=18171.

  • MLA

    Atlas Lithium Corporation. "Atlas Lithium's Neves Project is Now Permitted". AZoMining. 21 November 2024. <https://www.azomining.com/News.aspx?newsID=18171>.

  • Chicago

    Atlas Lithium Corporation. "Atlas Lithium's Neves Project is Now Permitted". AZoMining. https://www.azomining.com/News.aspx?newsID=18171. (accessed November 21, 2024).

  • Harvard

    Atlas Lithium Corporation. 2024. Atlas Lithium's Neves Project is Now Permitted. AZoMining, viewed 21 November 2024, https://www.azomining.com/News.aspx?newsID=18171.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.